Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry

NCT01792583 is registered in ClinicalTrials.gov with Cephalon, Inc. as lead sponsor.

NCT NCT01792583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01792583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry
Lead sponsor
Cephalon, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 30, 2009
Completion date
November 30, 2023
Enrollment
191 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy, obstructive sleep apnea, shift work sleep disorder